Author:
Parameshwaraiah Sumanth T,Malyam Vidhyavathi,Sannappa Asha C,Gopalakrishnan Vishnu Vardhan,Jindal Sanjana
Publisher
Jaypee Brothers Medical Publishing
Reference6 articles.
1. 1. Kwon JS, Jang JH, Kang DH, et al. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study. Psychiatr Clin Neurosci 2009;63(1):73–81. DOI: 10.1111/j.1440-1819.2008.01907.x
2. 2. Goodnick PJ, Jerry JM. Aripiprazole: profile on efficacy and safety. Expert Opin Pharmacother 2002;3(12):1773–1781. DOI: 10.1517/14656566.3.12.1773
3. 3. Ramage AG. The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol 2006;147(Suppl 2):S120–S131. DOI: 10.1038/sj.bjp.0706504
4. 4. Lecci A, Giuliani S, Santicioli P, et al. Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat. J Pharmacol Exp Ther 1992;262(1):181–189. PMID: 1352548.
5. 5. Hsu WY, Chang TG, Chiu NY. Aripiprazole associated urine retention in a male schizophrenia patient. Gen Hospital Psychiatr 2013;35(6):e680–e611. DOI: 10.1016/j.genhosppsych.2013.04.008